Literature DB >> 7953671

Staurosporine and K-252 compounds protect hippocampal neurons against amyloid beta-peptide toxicity and oxidative injury.

Y Goodman1, M P Mattson.   

Abstract

Recent studies have shown that amyloid beta-peptide (A beta) can be directly neurotoxic by a mechanism related to secondary structure of the peptide, and mediated by free radical production and an increase in the concentration of intracellular free calcium ([Ca2+]i). We now report that staurosporine and K-252 compounds, low molecular weight alkaloids of bacterial origin, can protect cultured rat hippocampal neurons against the toxicity of A beta in a concentration-dependent manner. The alkaloids also protected neurons against iron-induced (free radical-mediated) injury. Measurements of [Ca2+]i using fura-2 imaging revealed that the elevation of [Ca2+]i that occurred in response to long-term exposure to A beta was attenuated in neurons treated with staurosporine and K-252 compounds. These findings indicate that staurosporine and K-252 compounds can interupt a neurodegenerative pathway relevant to the pathophysiology of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7953671     DOI: 10.1016/0006-8993(94)90223-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  The nanometer-scale structure of amyloid-beta visualized by atomic force microscopy.

Authors:  W B Stine; S W Snyder; U S Ladror; W S Wade; M F Miller; T J Perun; T F Holzman; G A Krafft
Journal:  J Protein Chem       Date:  1996-02

Review 2.  Amyloid beta-peptide and oxidative cellular injury in Alzheimer's disease.

Authors:  R J Mark; E M Blanc; M P Mattson
Journal:  Mol Neurobiol       Date:  1996-06       Impact factor: 5.590

3.  Effect of beta-amyloid block of the fast-inactivating K+ channel on intracellular Ca2+ and excitability in a modeled neuron.

Authors:  T A Good; R M Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

4.  Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity.

Authors:  S Doré; S Kar; R Quirion
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

5.  Attenuation of microglial activation in a mouse model of Alzheimer's disease via NFAT inhibition.

Authors:  Lalida Rojanathammanee; Angela M Floden; Gunjan D Manocha; Colin K Combs
Journal:  J Neuroinflammation       Date:  2015-03-04       Impact factor: 8.322

Review 6.  c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer's Disease.

Authors:  Ramon Yarza; Silvia Vela; Maite Solas; Maria J Ramirez
Journal:  Front Pharmacol       Date:  2016-01-12       Impact factor: 5.810

Review 7.  Marine-derived protein kinase inhibitors for neuroinflammatory diseases.

Authors:  Chong Ning; Hui-Min David Wang; Rong Gao; Yu-Chia Chang; Fengqing Hu; Xianjun Meng; Shi-Ying Huang
Journal:  Biomed Eng Online       Date:  2018-04-24       Impact factor: 2.819

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.